New MRI scan could predict pancreatic cancer aggressiveness
NCT ID NCT06526442
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study explores whether a special MRI technique called 3D magnetic resonance elastography (MRE) can accurately measure the stiffness of pancreatic tumors and surrounding scar tissue. Researchers will enroll 200 adults with pancreatic cancer to see if these stiffness measurements can help predict how the cancer will respond to chemotherapy. The goal is to find a non-invasive way to guide treatment decisions without needing a biopsy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAGNETIC RESONANCE IMAGING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shengjing hospital of china medical university
RECRUITINGShenyang, Liaoning, 110004, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pancreatic Cancer's inflammatory footprint be stopped?
- A closer look: could hysteroscopy guide better repair of cesarean scar defects?
- Blood and gut clues may flag pancreatic cancer risk early
- Can brain scans and gut bacteria reveal Alzheimer's secrets?
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can a pill outsmart Tumors' defenses?